PHARMA 2100 ApS: Financial statements 2017
CVR: 26382785
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -20,455
- Profit/Loss
- DKK -20,455
- Equity
- DKK 29,371
- Total Assets
- DKK 29,371
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | -20 t. | -20 t. | 29 t. | - |
| 2016 | 0 | 0 | 0 | 50 t. | - |
| 2015 | - | -2 t. | -2 t. | 50 t. | - |
| 2014 | 0 | -5 t. | -5 t. | 52 t. | - |
| 2013 | 0 | -250 | -25 t. | 57 t. | - |
Official annual report
Keep an eye on PHARMA 2100 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 7, 2017, Niels Meidahl has stepped down as director of PHARMA 2100 ApS.
PHARMA 2100 ApS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 0.
As of April 12, 2017, Niels Meidahl is registered as director of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has left the board of directors of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has stepped down as adm. dir of PHARMA 2100 ApS.
As of January 16, 2017, Bella da Silva Buxbom has stepped down as chairman of PHARMA 2100 ApS.
About PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company has been dissolved on 23 October 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee (2009). In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371.